MicroStrategy(US:MSTR) Zhi Tong Cai Jing·2025-12-13 07:03Group 1 - Strategy (MSTR.US) has maintained its position in the Nasdaq 100 index for over a year, despite ongoing skepticism about its business model [1][2] - The company's "buy and hold" Bitcoin strategy resembles that of an investment fund, leading to the emergence of numerous imitators in the market [1] - Concerns about the sustainability of crypto asset reserve companies are increasing, with Strategy's stock price being highly sensitive to Bitcoin's volatility [1] Group 2 - Nasdaq has removed several companies, including Biogen (BIIB.US) and CDW (CDW.US), from the Nasdaq 100 index, while adding new constituents like Alnylam Pharmaceuticals (ALNY.US) and Seagate Technology (STX.US) [1] - Initially a software company, Strategy shifted to Bitcoin investment in 2020 and was included in the Nasdaq 100 index in December of the previous year [2] - MSCI has expressed concerns about including digital asset reserve companies in its benchmark index and is expected to make a decision regarding Strategy in January [2]